MedTech Exchange Boston 2026: Key Insights from Industry Leaders

Regulatory requirements continue to evolve, making compliance a lifecycle-wide responsibility rather than a point-in-time activity. Throughout the event, speakers highlighted the growing importance of t end-to-end traceability, evolving QMSR requirements, and tighter connections between regulatory, quality, and product development teams as organizations work to navigate increasingly complex requirements across global markets. These themes were reinforced during discussions on product risk management, regulatory records, and cybersecurity, where attendees explored practical approaches for maintaining compliance while continuing to innovate. This aligns closely with the industry's broader shift toward continuous compliance and end-to-end traceability.

Digital transformation is no longer just about system modernization. During the CONMED customer session, attendees heard firsthand how quality modernization, validation processes, cloud adoption, and organizational alignment must work together to drive meaningful change. Across multiple discussions, it became clear that MedTech organizations are looking beyond isolated technology investments and focusing on connected processes, shared data, and lifecycle-wide visibility to improve efficiency, reduce risk, and support long-term business goals.

From Kevin Wrenn's discussion on creating an intelligent product lifecycle to the afternoon session on the future of MedTech innovation, a recurring theme emerged: innovation is increasingly constrained by disconnected data, fragmented processes, and growing hardware-software complexity. As products become more connected, software-driven, and data-intensive, organizations need better visibility across engineering, quality, regulatory, manufacturing, and service functions. Industry leaders discussed how connected lifecycle strategies can help accelerate new product introduction while maintaining compliance and quality standards.

Quality is no longer measured solely through compliance outcomes. Discussions throughout the day emphasized the growing connection between quality performance, operational efficiency, patient outcomes, and business success. During strategy circle conversations focused on quality data and risk management, attendees explored how leading organizations are shifting from reactive quality processes toward more proactive, lifecycle-based approaches that help identify issues earlier, reduce rework, and improve organizational agility. The conversation reflected a broader industry shift toward connected quality processes and closed-loop feedback.

Artificial intelligence was one of the most discussed topics of the event. During Daniel Matlis's keynote and throughout networking conversations, attendees explored how AI is being applied across the medical device lifecycle to improve productivity, decision-making, and operational performance. The conversation focused not only on the opportunities AI presents but also on the importance of governance, traceability, and regulatory readiness as AI becomes increasingly embedded within MedTech products and processes. The takeaway was clear: organizations are moving beyond experimentation and beginning to focus on practical, scalable use cases that deliver measurable value.

Transforming the enterprise with the intelligent product lifecycle

View PTC’s product roadmap

Two seemingly different topics, cybersecurity and service, shared a common thread throughout the event: both require continuous lifecycle management. Discussions on cybersecurity highlighted the growing need for secure-by-design practices, end-to-end traceability, and post-market response readiness as devices become increasingly software-defined. Meanwhile, the session featuring GE Healthcare explored how service organizations are evolving from support functions into strategic business differentiators, using connected data and lifecycle insight to improve customer outcomes and create long-term value. Together, these discussions reinforced the importance of extending lifecycle thinking beyond product development and into post-market execution.

Attendees received an early look at upcoming innovations across PTC’s MedTech portfolio. Sessions explored enhancements to quality management, supply chain, and SaaS capabilities, along with PTC Jetstream and the evolving role of PTC Orbit as an intelligence layer across existing solutions. The discussion connected today’s capabilities with future opportunities to strengthen lifecycle visibility, support AI-enabled workflows, and help MedTech organizations respond to growing product and regulatory complexity.